로딩 중…
지수 로딩 중…
Medifast, Inc.
MED· NYSE· Consumer Discretionary· Retailing
$9.75-0.81%
2026-08-03
Financials
Valuation Metrics
Medifast, Inc.'s Market Cap is $108M. At end of 2025 it was $117M. Ranked #3075 of 3,112 in US market (top 99%), #1665 of 1,667 on NYSE (top 100%), #92 of 92 in Consumer Discretionary Distribution & Retail (top 100%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $108M | US#3,075/3,112 Sec#92/92 |
| Revenue | $346M | US#2,492/3,112 Sec#91/92 |
| Net Income | $-20M | US—/3,112 Sec—/92 |
| Total Assets | $252M | US#2,942/3,112 Sec#89/92 |
| Net Assets | $198M | US#2,740/3,112 Sec#83/92 |
| Value | ||
| P/B | 0.55x | US#79/3,112 Sec#1/92 |
| P/S | 0.31x | US#151/3,112 Sec#11/92 |
| EV/EBITDA | 8.36x | US#533/3,112 Sec#17/92 |
| FCF Yield | -1.36% | US—/3,112 Sec—/92 |
| Profitability | ||
| ROE | -10.13% | US#2,412/3,112 Sec#80/92 |
| ROA | -7.94% | US#2,605/3,112 Sec#82/92 |
| Op. Margin | -4.06% | US#2,544/3,112 Sec#84/92 |
| Revenue Growth | -34.29% | US#2,840/3,112 Sec#94/92 |
| Earnings Growth | -992.97% | US#2,366/3,112 Sec#78/92 |
| Financial Health | ||
| Debt Ratio | 27.50% | US#296/3,112 Sec#3/92 |
| Total Debt | $16M | US#2,732/3,112 Sec#89/92 |
| FCF | $-1M | US#2,280/3,112 Sec#72/92 |
| Cash | $72M | US#2,402/3,112 Sec#79/92 |
| Current Ratio | 4.80x | US#493/3,112 Sec#12/92 |
| Net Debt/EBITDA | -8.74x | US#36/3,112 Sec#2/92 |
| Dividend | ||
| Div. Yield | 0.08% | US#1,688/3,112 Sec#44/92 |
| Div. Growth | -72.73% | US—/3,112 Sec—/92 |
| Performance | ||
| 1Y Return | -29.09% | US#2,718/3,112 Sec#75/92 |
| 1M Return | -11.04% | US#2,655/3,112 Sec#80/92 |
| From 52W High | -35.47% | US#2,379/3,112 Sec#73/92 |
| 1Y MDD | -37.38% | US#1,823/3,112 Sec#48/92 |
| Trading | ||
| Volume | 206,281 shares | US#2,643/3,112 Sec#80/92 |
| Trading Value | $2M | US#2,913/3,112 Sec#90/92 |
| Per Share | ||
| EPS | $-1.70 | US—/3,112 Sec—/92 |
| BPS | $18.10 | US#1,300/3,112 Sec#42/92 |